Hulstaert E
ORCID: 0000-0002-4610-4599
· 1 paper in corpus
other
2022
BACKGROUND: Most ovarian cancer patients are diagnosed at an advanced stage and have a high mortality rate. Current screening strategies fail to improve prognosis because markers that are sensitive for early stage disease are lacking. This …